GlaxoSmithKline reported GBP5.2B in Gross Profit on Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Alcon AG ALC:SW USD 1.17B 83M
Amgen AMGN:US USD 5.09B 28M
Artemis Alpha ATS:LN GBP -26370000 16.4M
AstraZeneca AZN:LN USD 8.86B 3M
Bayer BAYN:GR EUR 7.03B 105M
Biogen BIIB:US USD 2.04B 66.1M
Bristol Myers Squibb BMY:US USD 8.89B 21M
Eli Lilly And LLY:US USD 5.75B 391.2M
Fresenius FRE:GR EUR 2.7B 27M
Fresenius Medical Care FME:GR EUR 1.36B 12.59M
Galapagos GLPG:NA EUR 145.65M 713K
Gilead Sciences GILD:US USD 5.99B 346M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Glaxosmithkline GSK:US GBP 5.2B 244M
Hikma Pharmaceutical HIK:LN USD 623M 62M
Merck MRK:GR EUR 3.66B 200M
Merk MRK:US USD 10.47B 610M
Novartis NOVN:VX USD 9.18B 151M
Orion ORNBV:FH EUR 355.7M 182.2M
Pfizer PFE:US USD 14.47B 2.08B
Philips PHIA:NA EUR 2.22B 491M
Recordati REC:IM EUR 330.13M 9.42M
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Roche Holding ROG:VX 22.73B 924M
Smith & Nephew PLC SN/:LN 1.83B 49M